Polytech Health & Aesthetics, Dieburg (Germany)

High-quality silicone implants

Key facts at a glance

  • Internationalisation of the business and optimisation of production processes
  • Expansion of manufacturing capacities and direct sales organisation
  • Ramp-up of patented lightweight implants 

Revenues in €mn

 

51

 

2019

 

46

 

2020

 

55

 

2021
Investment by
DBAG Fund VI
€79.7mn
DBAG's interest
€15.2mn
Management Buyout

Majority investment of DBAG Fund VI
First invested
October 2016

As of 30 September 2022

 

Profile

Polytech is a leading player in Europe in the development and production of silicone implants and is the sole German manufacturer of such products. The company specialises in breast implants used in reconstructive surgery after illness and in aesthetic plastic surgery.

The company has grown strongly in recent years. This expansion is based on production (under clean-room conditions) in Germany, which conforms to the highest quality standards, and the company’s innovative capacity. Polytech has developed surface textures for its products that lead to a clear reduction in the rate of complications.

We help Polytech to focus squarely on further developing the implants for medical use and to highlight its excellent “Made in Germany” seal of quality. The fact that we were able to find a solution to the future of this family-owned company by means of a management buyout is once again evidence of the high esteem in which we are held by German SMEs.

Kai Wiesenbach
Managing Director

17

per cent

average annual revenue growth between 2016 and 2019

Potential for development

In view of the very positive response to implants “Made in Germany”, Polytech has considerably expanded its sales activities. At the moment, the company generates around 40 per cent of its revenues in Germany and around 30 per cent in other European countries. However, its implants are increasingly being distributed worldwide, currently in over 70 countries. Polytech serves a growth market, driven by a number of factors including rising prosperity and demographic change in industrialised countries.

Contact

Kai Wiesenbach
Kai Wiesenbach
Kai Wiesenbach
+49 69 95787-238

Kai Wiesenbach

Managing Director

Kai Wiesenbach joined Deutsche Beteiligungs AG in 2004 and became a Managing Director in 2010.

He holds a degree in Business Administration from Goethe University, Frankfurt.

Kai Wiesenbach can look back on 17 years of experience in private equity. During that time, he gained extensive expertise, particularly in mechanical and plant engineering and the automotive supplier sector. He was involved in numerous acquisitions and realisations, including Coperion, Heim & Haus and Lewa. He led the investment process in Formel D and More than Meals and sits on the advisory council of More than Meals.

Current portfolio companies

Polytech Health & Aesthetics More than Meals

Former portfolio companies